Total Payments
$825.81
2020 Payments
$110.12
Companies
14
Transactions
31
Medicare Patients
900
Medicare Billing
$70,387
Payment Breakdown by Category
Food & Beverage$825.81 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $825.81 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $215.34 | 6 | $0 (2019) |
| GlaxoSmithKline, LLC. | $144.81 | 4 | $0 (2020) |
| PFIZER INC. | $130.35 | 4 | $0 (2019) |
| Novo Nordisk Inc | $90.96 | 2 | $0 (2018) |
| Lilly USA, LLC | $44.44 | 3 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.99 | 2 | $0 (2019) |
| Depomed, Inc. | $33.91 | 2 | $0 (2017) |
| Shire North American Group Inc | $31.20 | 2 | $0 (2018) |
| Amgen Inc. | $23.58 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $18.28 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $110.12 | 2 | GlaxoSmithKline, LLC. ($96.44) |
| 2019 | $203.26 | 8 | PFIZER INC. ($99.74) |
| 2018 | $224.34 | 10 | AstraZeneca Pharmaceuticals LP ($97.41) |
| 2017 | $288.09 | 11 | AstraZeneca Pharmaceuticals LP ($105.72) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/18/2020 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $96.44 | General |
| Category: VACCINES | ||||||
| 02/12/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Neuroscience | ||||||
| 11/13/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: RESPIRATORY | ||||||
| 08/07/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Vyvanse (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Central Nervous System (CNS) | ||||||
| 07/11/2019 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.17 | General |
| Category: Opioid Analgesic | ||||||
| 06/27/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $88.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/12/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: RESPIRATORY | ||||||
| 05/29/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 04/10/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.21 | General |
| Category: Respiratory | ||||||
| 08/14/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 06/06/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: Respiratory | ||||||
| 05/23/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $85.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/02/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: VACCINES | ||||||
| 04/24/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Dexilant (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Upper GI | ||||||
| 03/27/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: NEUROSCIENCE | ||||||
| 02/27/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/14/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Diabetes | ||||||
| 02/06/2018 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Diabetes | ||||||
| 01/31/2018 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2017 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/05/2017 | Depomed, Inc. | Nucynta (Drug), Gralise | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Pain | ||||||
| 05/25/2017 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $71.44 | General |
| 04/20/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $93.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 6 | 365 | 580 | $106,244 | $34,286 |
| 2020 | 11 | 535 | 727 | $125,565 | $36,102 |
Total Patients
900
Total Services
1,307
Medicare Billing
$70,387
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 179 | 325 | $58,706 | $17,892 | 30.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 97 | 162 | $42,830 | $13,740 | 32.1% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 27 | 27 | $1,782 | $1,782 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 31 | 31 | $1,736 | $541.88 | 31.2% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 17 | 21 | $441.00 | $194.20 | 44.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 14 | 14 | $749.00 | $135.96 | 18.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 135 | 211 | $53,805 | $14,203 | 26.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 148 | 243 | $42,396 | $10,491 | 24.7% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2020 | 54 | 54 | $3,564 | $3,294 | 92.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 27 | 30 | $8,970 | $2,487 | 27.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 18 | 18 | $4,932 | $2,167 | 43.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 72 | 80 | $4,480 | $1,390 | 31.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 20 | 22 | $4,730 | $1,117 | 23.6% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 13 | 16 | $624.00 | $310.49 | 49.8% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 19 | 24 | $504.00 | $231.14 | 45.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 13 | 13 | $728.00 | $224.14 | 30.8% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 16 | 16 | $832.00 | $187.14 | 22.5% |
About Dr. Robert Dagostino, MD
Dr. Robert Dagostino, MD is a Family Medicine healthcare provider based in Milford, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1801953260.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Dagostino, MD has received a total of $825.81 in payments from pharmaceutical and medical device companies, with $110.12 received in 2020. These payments were reported across 31 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($825.81).
As a Medicare-enrolled provider, Dagostino has provided services to 900 Medicare beneficiaries, totaling 1,307 services with total Medicare billing of $70,387. Data is available for 2 years (2020–2021), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Milford, NH
- Active Since 01/03/2007
- Last Updated 10/18/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1801953260
Products in Payments
- FARXIGA (Drug) $179.11
- BEXSERO (Biological) $96.44
- ELIQUIS (Drug) $88.50
- Nucynta (Drug) $33.91
- MYDAYIS (Drug) $31.20
- CHANTIX (Drug) $26.71
- SYMBICORT (Drug) $24.35
- Aimovig (Biological) $23.58
- BREO (Drug) $20.91
- Vyvanse (Drug) $19.82
- Victoza (Drug) $19.52
- ENTRESTO (Drug) $18.28
- XTAMPZA (Drug) $18.17
- TRELEGY ELLIPTA (Drug) $15.64
- JARDIANCE (Drug) $15.42
- ELELYSO (Drug) $15.14
- TRULICITY (Drug) $14.71
- HUMALOG (Drug) $14.31
- Dexilant (Drug) $14.17
- SPIRIVA RESPIMAT (Drug) $14.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Milford
Dr. Joseph Cirello, Md, MD
Family Medicine — Payments: $12,202
Family Medicine $12,202
Dr. Victor Angel, D.o, D.O
Family Medicine — Payments: $9,634
Family Medicine $9,634
Dr. Barry Rubin, D.o, D.O
Family Medicine — Payments: $7,737
Family Medicine $7,737
Dennis Ward, Do, DO
Family Medicine — Payments: $4,565
Family Medicine $4,565
Lauren Parmer, Do, DO
Family Medicine — Payments: $3,229
Family Medicine $3,229
Preeti Gupta, M.d, M.D
Family Medicine — Payments: $3,175
Family Medicine $3,175